BioAsia 2017 Program

February 6, 2017 8:30 - 16:30 Hrs

BioPark Visit

18:00 - 19:30 Hrs

Inauguration of the 14th BioAsia Convention (Presentation of Genome Valley Excellence Award)

19:30 - 20:00 Hrs

Visit to the exhibition

20:00 Hrs

Welcome Reception (only for invitees) February 7, 2017

8:30 – 9:20 Hrs

India-Illinois Power Breakfast Meeting (Only for Invitees)

9:30 - 10: 00 Hrs

Keynote Addresses: Nobel Laureate Prof. Kurt Wuthrich, Scripps Research Institute, USA

10:00 - 10: 30 Hrs

Keynote Address: Dr. Paul Stoffels, Worldwide Chairman of Pharma, Chief Scientific Officer, Johnson & Johnson, USA

10:30 - 11: 00 Hrs

Keynote Address: Dr. Vasant Narasimhan, Global Head of Drug Development & CMO, Novartis, Switzerland

11:00 - 11:30 Hrs

Networking Break & Visit to the Exhibition Innovation Conference Plenary Address on Disruptive Innovation  Emerging technologies - nanobots, combination devices, 3D printing  Traditional vs innovation approach to clinical research/biotech-pharma research  Companies leading the way (Google) &Industry trends

11:30 – 12:15 Hrs 12:15 – 13:30 Hrs

Speakers: Enabling Open Innovation (Panel Discussion)  Introduction to open innovation  Solving complex problems with open innovation model  Executing an open innovation model  Pitfalls to avoid Opening Remarks: Dr. Renu Swarup, MD, BIRAC, Dept. of Biotechnology, Govt. of India Chairman: Mr. BVR Mohan Reddy, Founder & Chairman, Cyient, India Panelists:  Padma Vibhushan Dr. R A Mashelkar, National Research Professor & President, Global ResearchAlliance& Former DG, CSIR  Dr. Murtaza Khorakiwala, Managing Director, Wockhardt, India  Mr. Ranjit Shahani, Chairman &MD, Novartis, India*  Mr. Manni Kantipudi, CEO, GVK Biosciences, India*  Mr. Edgard Olaizola,Managing Director, Eli Lilly India*  Mr. Brian Toohley, SVP International, Pharmaceutical Research & Manufacturers of America (PhRMA), USA

Automation in Diagnostics Conference Under Chairmanship of Dr. Shanthi Naidu

TB Conference TBD



Mr.

Moderator:Pad Distinguished Scientist Eye Institute 13:30 – 14:30 Hrs

Mohan Pandey, &Head of BBRC Center), Bristol-Myers

Executive Director (Biocon BMS R&D Squibb

ma Shri Dr. D & Director Emeritus -

Balasubramanian, Research, LV Prasad

Networking Lunch& Visit to the Exhibition Patent protection and value of Innovation and R&D  Ways for pharma companies to continue to innovate in this new world and come up with drugs of the future  Patent protection to help fuel that growth of innovation (by providing protection from infringement, continuing to provide sufficient time to help invest in innovation)  Pharma companies taking additional investments to ensure compliance with regulations and meet the larger goal of improving health outcomes.

14:30 – 15:45 Hrs

15:45 – 16:15 Hrs

16:15 – 17:30 Hrs

Panelists:  Mr. Rajiv Aggarwal, Joint Secretary, DIPP, Govt. of India &Convenor of the Innovation Task Force, Cell for IPR Promotion and Management (CIPAM), DIPP*  Dr. Anil Koul, Director, CSIR-Institute of Microbial Technology, India  Dr. S. Chandrasekhar, Director, CSIR-Indian Institute of Chemical Technology  Mr. K G Ananthakrishnan, Managing Director, MSD India  Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech International Ltd., India*  Ms. Amiee Aloi Associate Vice President, International Advocacy, PhRMA, USA  Prof. Prabhudha Ganguli, Advisor, VISION-IPR, India* Networking Lunch& Visit to the Exhibition Design Led Thinking  Finding the right problem  Essential principles and frameworks  How biotech/pharma embraces the principles of design led thinking Chairman: Padma Shri Dr. D Balasubramanian, Distinguished Scientist & Director Emeritus Research, LV Prasad Eye Institute Panelists:  Mr. Parameswaran Venkataraman,VP & Studio 5B Lead,Innovation and Design Centre, Dr. Reddy's Laboratories  Mr. Yashdeep Kumar, Vice President, Global Innovation Programs, Stryker Corporation, USA  Mr. Manoj Kothari, Managing Director- Turian Labs, Co-founder- Onio Design Pvt. Ltd  Dr. Arun Mazumdar, Stanford University, USA* Moderator: Mr. Sudeep Krishna, Senior Director and Head Lifesciences, Monitor Deloitte - Deloitte Consulting

17:30 – 18:30 Hrs

Networking Break& Visit to the Exhibition

18:30 - 20:00 Hrs

CEO CONCLAVE SERVING A BILLION NEW PATIENTS - Role that Indian Life Sciences Industry can play Panelists:



   

Shri.

KT Rama Rao, Hon’ble Communication, Development and NRI Amitabh Kant, CEO, Vas Narasimhan,

 Mr.  Mr. (worldwide) for Novartis Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories Mr. Nilesh Gupta, Managing Director, Lupin* Mr. Glenn Saldhana, Chairman and Managing Director, Glenmark Pharmaceuticals Mr. Bhaskar Iyer, Vice President, Established Pharmaceuticals, Abbott, India

Minister for Industries, IT, Electronics, Municipal Administration, Urban Affairs, Government of Telangana NITI Aayog, Government of India* Global Head of Drug Development and Chief Medical Officer

February 8, 2017 8:30 – 9:20 Hrs

BioAsia OPPI Women in Pharma Breakfast Session (Only for Invitees)

9:30 - 10: 00 Hrs

Keynote Addresses: Mr. Narayana Murthy, Founder, Infosys

10:00 - 10: 30 Hrs

Keynote Addresses: Dr. Patrick Vallance, President R&D, GSK, UK Manufacturing Conference

10:30 – 11:45 Hrs

11:45 – 12:15 Hrs

Digital Health and Healthcare IT Conference

The Power of Manufacturing Clusters – Make in India (Panel Discussion)  Govt. initiatives to promote pharmaceutical manufacturing  Infrastructure, incentives, and advantage offered by manufacturing clusters  Investment opportunities  Are we on the right track?

Health IT - Adoption in India (Panel Discussion)  IT penetration in Indian healthcare landscape  Lessons from other markets  Innovations, Current and emerging technologies  Challenges to adoption  How technology enabled care can transform healthcare  Telemedicines

Panelists:  Mr. Sudhansh Pant, Joint Secretary, Department of Pharmaceuticals, Government of India*  Mr. Sudhanshu Pandey, Joint Secretary, Department of Commerce, Government of India*  Dr. VM Katoch, Former Secretary, Health Research & Former DG, ICMR  Mr. R Ananthanarayanan, President & CEO, Teva Pharmaceutical Industries Ltd.*  Mr. Srini Srinivasan, MD, Hospira  Mr. Mathew Szuhaj, Managing Director, Deloitte  Mr. Milan Rao, President & CEO, GE Healthcare - India & South Asia, GE Healthcare*  Mr. Kal Sundaram, India CEO, Sun Pharma*  Dr. Sharvil P. Patel, Deputy Managing Director, Zydus Cadila*

Chairman: Ms. Sangita Reddy, Joint Chairman, Apollo Hospitals* Speakers:  Mr. Anil Bhansali, MD, Microsoft India (R&D) Pvt. Ltd.*  Mr. N. Chandrasekaran, CEO & Managing Director, TCS India*  Ms. Vanitha Narayanan, Managing Director, IBM India Private Limited *  Mr. Dinesh Malkani, President, Cisco India*  Mr. Srinivas Prasad, CEO, Philips Innovation Campus*  Dr. Harish Iyer, Advisor, Bill & Melinda Gates Foundation  Mr. Mukesh Rathi,VP & CIO, Dr. Reddy's Laboratories*  Ms. Swati Subodh, Cofounder & Director, Healthcare Innovations  Mr. Jeyaseelan Jeyaraj, Director Oracle Health Sciences, Asia Pacific Oracle Corporation*  Mr. Joe Kvedar, Vice President of Connected Health, Partners HealthCare*

Networking Break& Visit to the Exhibition

Moderator:Dr. Anthony Vipin Das, LV Prasad Eye Institute

Health & Access Conference

In partnership with IFCAI

Manufacturing (Q&A Session)  12:15 – 13:30 Hrs 

- Impact of regulators

Digital Health: Will startups drive the growth?

(Panel Discussion)  India's healthcare startup story  Government initiatives supporting

Quality and regulatory concerns Limitations of current

 regulatory regime Industry response to the increased regulatory scrutiny

Panelists:  Dr. Mathew T. Thomas, Director India, USFDA*  Mr. Rajeev Nannapaneni, VC & CEO, Natco Pharma*  Dr. GN Singh, DCGI, Chairman, CDCSO India*  Mr.N Govindarajan, Managing Director, Aurobindo Pharma*  Dr. Mahesh Bhalgat, ED & COO, Shantha Biotechnics  Mr. R.C. Juneja, CEO & Chairman, Mankind Pharma Ltd.*  Dr. Satyanarayana Chava, CEO, Laurus Labs*  Ms. Mahima Datla, Sr. Vice President, Biological E. Ltd.*

entrepreneurs Chair: Mr. Rajan Anandan , Vice President, South East Asia and India, Google* Speakers:  Mr. CP Gurnani, CEO and Managing Director, Tech Mahindra  Mr. Shashank ND, Founder & CEO, Practo  Mr. Prashant Tandon, Co-founder, 1 Mg  Mr. Bobba Venkatadri, General Partner, Ventureast  Mr. Apoorva Patni, Director, Currae Healthcare - Patni Enterprise  Dr. Anand Gnanaraj, Founding Member & CMO, Attune Technologies* Moderator:Mr. Jay Krishnan, CEO, T-hub Hyderabad

13:30 – 14:30 Hrs

14:30 – 15:45 Hrs

15:45 – 16:15 Hrs 16:15 – 17:15 Hrs

Networking Lunch & Visit to the Exhibition GST and its Impact on Supply Chain (Panel Discussion)  Impact of GST on business operations  Place of Supply provisions  impact on procurement & distribution  New supply chain models Panelists:  Mr. S Sridhar, MD, Pfizer India  Mr. A. Vaidheesh, VP, South Asia & MD India, GSK  Mr. Anurag Roy,VP & Business Unit Director, DSM Sinochem Pharmaceuticals, India  Dr. Rajiv Modi, CMD, Cadila Pharmaceuticals*  Mr. Umang Vohra, MD & Global CEO, Cipla*  Mr. Varun Khanna, MD, BD India*  Dr. Cyrus Karkaria, President Biotechnology, Lupin*  Dr. Shravan Subramanyam, Managing Director, Roche Diagnostics India & Neighboring Markets* Networking Break& Visit to the Exhibition

Investments & Funding in Digital Health (Panel Discussion)  Current investment focus within healthcare  Major drivers for investments  Opportunities for emerging players/start-ups Speakers:  TBD, Saif Partners*  TBD, TPG*  Mr. Bobba Venkatadri, General Partner, Ventureast  TBD, Nexus*

Start-Up &Healthcare Challenge Session